Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jit

Showing results (181-190 of 407) with videos related to

Pageof 41
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2021
Every Country, Every Family: Time to Act for Group B Streptococcal Disease WorldwideJoy E Lawn, Jaya Chandna, Proma Paul, et al.
Influenza and Other Respiratory Viruses|December 26, 2024
The Impact of Public Health and Social Measures (PHSMs) on SARS-CoV-2 Transmission in the WHO European Region (2020-2022)Yang Liu, Charlie Diamond, Sam Abbott, et al.
Vaccine|January 16, 2021
Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose scheduleHilary S Whitworth, John Schiller, Lauri E Markowitz, et al.
BMC Medicine|July 12, 2011
Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the worldMaarten J Postma, Mark Jit, Mark H Rozenbaum, et al.
The Journal of Infectious Diseases|March 16, 2022
Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian ChildrenXiao Li, Joke Bilcke, Liliana Vázquez Fernández, et al.
Emerging Themes in Epidemiology|May 9, 2013
Trends in parameterization, economics and host behaviour in influenza pandemic modelling: a review and reporting protocolLuis R Carrasco, Mark Jit, Mark I Chen, et al.
Nature Communications|December 9, 2025
COVID-19 pandemic and waning immunity disrupted measles population immunity and strategies to close immunity gapsWei Wang, Qianli Wang, Sihong Zhao, et al.
Vaccine|March 5, 2026
The epidemiological effect and cost-effectiveness of expanded age eligibility for recombinant zoster vaccination in EnglandChu-Chang Ku, Alicia Rosello, Jemma Walker, et al.
Frontiers in Public Health|September 13, 2021
An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and LimitationsHugo C Turner, Rachel A Archer, Laura E Downey, et al.
BMJ Global Health|August 30, 2023
Analyses of the return on investment of public health interventions: a scoping review and recommendations for future studiesHugo C Turner, Yoshiaki Hori, Paul Revill, et al.
Pageof 41

Showing results (181-190 of 407) with videos related to

Sort By:
Pageof 41
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2021
Every Country, Every Family: Time to Act for Group B Streptococcal Disease WorldwideJoy E Lawn, Jaya Chandna, Proma Paul, et al.
Influenza and Other Respiratory Viruses|December 26, 2024
The Impact of Public Health and Social Measures (PHSMs) on SARS-CoV-2 Transmission in the WHO European Region (2020-2022)Yang Liu, Charlie Diamond, Sam Abbott, et al.
Vaccine|January 16, 2021
Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose scheduleHilary S Whitworth, John Schiller, Lauri E Markowitz, et al.
BMC Medicine|July 12, 2011
Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the worldMaarten J Postma, Mark Jit, Mark H Rozenbaum, et al.
The Journal of Infectious Diseases|March 16, 2022
Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian ChildrenXiao Li, Joke Bilcke, Liliana Vázquez Fernández, et al.
Emerging Themes in Epidemiology|May 9, 2013
Trends in parameterization, economics and host behaviour in influenza pandemic modelling: a review and reporting protocolLuis R Carrasco, Mark Jit, Mark I Chen, et al.
Nature Communications|December 9, 2025
COVID-19 pandemic and waning immunity disrupted measles population immunity and strategies to close immunity gapsWei Wang, Qianli Wang, Sihong Zhao, et al.
Vaccine|March 5, 2026
The epidemiological effect and cost-effectiveness of expanded age eligibility for recombinant zoster vaccination in EnglandChu-Chang Ku, Alicia Rosello, Jemma Walker, et al.
Frontiers in Public Health|September 13, 2021
An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and LimitationsHugo C Turner, Rachel A Archer, Laura E Downey, et al.
BMJ Global Health|August 30, 2023
Analyses of the return on investment of public health interventions: a scoping review and recommendations for future studiesHugo C Turner, Yoshiaki Hori, Paul Revill, et al.
Pageof 41